Novartis says Cosentyx could be used as an early intervention in psoriasis after new data suggests it is the first drug of its kind to modify the course of the disease. The Swiss big pharma ...

Cosentyx belongs to a newer class of drugs that inhibit IL-17, and Novartis is aiming to encourage doctors to use it with longer term data showing that its benefits persist after five years, as ...

It’s not known whether Cosentyx (secukinumab) is safe to receive while pregnant or breastfeeding. Certain factors may determine whether you should receive the drug during this time. Doctors ...

Cosentyx (secukinumab) may be safe to use while pregnant or breastfeeding. Before starting treatment, you and your doctor can discuss the risks and benefits of Cosentyx treatment during pregnancy ...

Cosentyx (secukinumab) is used to treat certain autoimmune conditions. If you’re stopping treatment or switching drugs, you may wonder how long Cosentyx stays in your system. Keep reading to ...

LONDON, GREATER LONDON, UNITED KINGDOM, March 18, 2025 /EINPresswire / -- How Much Is the Cosentyx Drug Market Growing? The global Cosentyx drug market is set for significant expansion ...

Cosentyx sales surpassed $6 billion, growing 25% for the year, driven by new launches in HS and IV formulations. The brand ...